These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13345615)

  • 1. Efficacy of trivalent adenovirus (APC) vaccine in naval recruits.
    BELL JA; HANTOVER MJ; HEUNER RJ; LOOSLI CG
    J Am Med Assoc; 1956 Aug; 161(16):1521-5. PubMed ID: 13345615
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a trivalent adenovirus vaccine for prevention of acute respiratory disease in naval recruits.
    GUNDELFINGER BF; HANTOVER MJ; BELL JA; LOOSLI CG; ROWE WP
    Am J Hyg; 1958 Sep; 68(2):156-68. PubMed ID: 13571230
    [No Abstract]   [Full Text] [Related]  

  • 3. Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations.
    HILLEMAN MR
    AMA Arch Intern Med; 1958 Jan; 101(1):47-53. PubMed ID: 13486965
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenovirus infections in naval recruits.
    GRAYSTON JT; WOOLRIDGE RL; LOOSLI CG; GUNDELFINGER BF; JOHNSTON PB; PIERCE WE
    J Infect Dis; 1959; 104(1):61-70. PubMed ID: 13631288
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits.
    Choudhry A; Mathena J; Albano JD; Yacovone M; Collins L
    Vaccine; 2016 Aug; 34(38):4558-4564. PubMed ID: 27475474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on acute respiratory illness in naval recruits, with emphasis on the adenoviruses (APC-RI).
    FRIEDMAN M; GRAYSTON JT; LOOSLI CG; PIERCE WE; WHITESIDE JE; WOOLRIDGE RL
    J Infect Dis; 1956; 99(2):182-7. PubMed ID: 13376912
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine.
    HILLEMAN MR; STALLONES RA; GAULD RL; WARFIELD MS; ANDERSON SA
    Proc Soc Exp Biol Med; 1956 Jun; 92(2):377-83. PubMed ID: 13350354
    [No Abstract]   [Full Text] [Related]  

  • 8. Appraisal of occurrence of adenovirus-caused respiratory illness in military populations.
    HILLEMAN MR; GAULD RL; BUTLER RL; STALLONES RA; HEDBERG CL; WARFIELD MS; ANDERSON SA
    Am J Hyg; 1957 Jul; 66(1):29-41. PubMed ID: 13444254
    [No Abstract]   [Full Text] [Related]  

  • 9. Outbreak of adenovirus infection in the Portsmouth Naval Command, 1958.
    FRASER PK; HATCH LA
    Br Med J; 1959 Feb; 1(5120):470-3. PubMed ID: 13629022
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of adenovirus infection in the respiratory diseases of naval recruits. A longitudinal study of two companies of naval recruits.
    MCNAMARA MJ; PIERCE WE; CRAWFORD YE; MILLER LF
    Am Rev Respir Dis; 1962 Oct; 86():485-97. PubMed ID: 13932225
    [No Abstract]   [Full Text] [Related]  

  • 11. DOSAGES OF VARIOUS TRIVALENT AND MONOVALENT ADENOVIRUS VACCINES IN THE PROPHLAXIS OF ACUTE RESPIRATORY ILLNESS.
    STILLE WT; HANTOVER MJ
    Am J Hyg; 1964 Jul; 80():121-34. PubMed ID: 14192764
    [No Abstract]   [Full Text] [Related]  

  • 12. Reemergence of adenovirus type 4 acute respiratory disease in military trainees: report of an outbreak during a lapse in vaccination.
    Barraza EM; Ludwig SL; Gaydos JC; Brundage JF
    J Infect Dis; 1999 Jun; 179(6):1531-3. PubMed ID: 10228076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus (RI-APC-ARD) vaccine for prevention of acute respiratory illness. I. Vaccine development.
    ANDERSON SA; HILLEMAN MR; WARFIELD MS; WERNER JH
    J Am Med Assoc; 1957 Jan; 163(1):4-15. PubMed ID: 13376334
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of adenovirus vaccine on acute respiratory disease in U. S. Army recruits.
    SHERWOOD RW; BUESCHER EL; NITZ RE; COOCH JW
    JAMA; 1961 Dec; 178():1125-7. PubMed ID: 13911749
    [No Abstract]   [Full Text] [Related]  

  • 15. Trial of adenovirus vaccine in Royal Air Force recruits.
    WILSON JS; GRANT PJ; MILLER DL; TAYLOR CE; McDONALD JC
    Br Med J; 1960 Apr; 1(5179):1081-3. PubMed ID: 13845090
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination against acute respiratory illness of adenovirus (RI-APC-ARD) etiology.
    HILLEMAN MR; STALLONES RA; GAULD RL; WARFIELD MS; ANDERSON SA
    Am J Public Health Nations Health; 1957 Jul; 47(7):841-7. PubMed ID: 13435388
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of adenovirus respiratory infections in military recruit populations.
    HILLEMAN MR
    Ann N Y Acad Sci; 1957 Apr; 67(8):262-72. PubMed ID: 13411964
    [No Abstract]   [Full Text] [Related]  

  • 18. Current use and future directions of adenovirus vaccine.
    Gurwith MJ; Horwith GS; Impellizzeri CA; Davis AR; Lubeck MD; Hung PP
    Semin Respir Infect; 1989 Dec; 4(4):299-303. PubMed ID: 2560582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. II.
    STILLE WT; SCHULTZ I; GUNDELFINGER BF; MILLER LF
    Am J Public Health Nations Health; 1962 Feb; 52(2):275-89. PubMed ID: 13917238
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits.
    Hyer RN; Howell MR; Ryan MA; Gaydos JC
    Am J Trop Med Hyg; 2000 May; 62(5):613-8. PubMed ID: 11289673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.